New web tool aims to help cancer patients make sense of their genes
NCT ID NCT04905082
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a web-based education tool called HOPE-Genomics that teaches cancer patients about their genetic test results. About 465 adults with breast, colorectal, lung, ovarian, pancreatic, or prostate cancer are taking part. The goal is to see if the tool helps patients remember and understand their genomic information, which could lead to better care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- HOPE-Genomics web-based education tool
- What this could lead to
- If it works, this tool could help cancer patients better understand their genetic test results and improve the quality of their care.
- What could go wrong
- This is a behavioral study, not a treatment trial. It may not show a meaningful improvement in patient knowledge or care outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
City of Hope Medical Center
Duarte, California, 91010, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Phone-Based navigation could boost breast cancer detection in kenya
- Shockwaves may speed up erectile recovery after prostate cancer surgery
- Can a new PET tracer reveal hidden immune clues in tumors?
- A simple blood draw could spot colorectal cancer early
- MRI screening may spot pancreatic cancer sooner in High-Risk gene carriers
- Can a Cancer-Fighting virus shrink tumors when chemo fails?